Drug Guide

Generic Name

Triprolidine Hydrochloride

Brand Names Actidil, Myidyl

Classification

Therapeutic: Antihistamine, Alleviates allergy symptoms

Pharmacological: H1-antagonist

FDA Approved Indications

Mechanism of Action

Triprolidine is a reversible H1 receptor antagonist that competes with histamine for binding at H1 receptor sites on effector cells in the GI tract, blood vessels, and respiratory tract, thereby preventing smooth muscle constriction and capillary permeability associated with allergic responses.

Dosage and Administration

Adult: Usually 2-4 mg every 4-6 hours as needed, not exceeding 24 mg/day

Pediatric: Typically 0.25-0.5 mg/kg/day divided into 3-4 doses, not exceeding adult dose; specific pediatric dosing varies by age and weight

Geriatric: Start at the lower end of dosing; monitor for increased sensitivity to side effects

Renal Impairment: Use with caution; may require dose adjustment, as elimination may be affected

Hepatic Impairment: Use with caution; monitor closely; no specific adjustment established

Pharmacokinetics

Absorption: Well absorbed from the gastrointestinal tract

Distribution: Widely distributed; crosses the blood-brain barrier

Metabolism: Extensively metabolized in the liver

Excretion: Primarily excreted in urine

Half Life: Approx. 4-6 hours, may be prolonged in hepatic or renal impairment

Contraindications

Precautions

Adverse Reactions - Common

Adverse Reactions - Serious

Drug-Drug Interactions

Drug-Food Interactions

N/A

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Monitor for effectiveness and side effects, especially CNS effects and anticholinergic symptoms

Diagnoses:

  • Risk for sedation-related incidents
  • Urinary retention
  • Dry mucous membranes

Implementation: Administer with food if gastrointestinal upset occurs, monitor sedation levels

Evaluation: Assess symptom relief and side effect profile regularly

Patient/Family Teaching

Special Considerations

Black Box Warnings: N/A

Genetic Factors: None specifically identified

Lab Test Interference: May interfere with allergy skin testing; discontinue prior to testing

Overdose Management

Signs/Symptoms: Severe drowsiness, hallucinations, seizures, dry mouth, tachycardia, urinary retention, hypotension

Treatment: Supportive care, activated charcoal if within 1 hour of ingestion, symptomatic treatment for respiratory and cardiovascular issues, possible IV fluids, and monitoring

Storage and Handling

Storage: Store at room temperature, away from light and moisture

Stability: Stable until expiration if stored properly

This guide is for educational purposes only and is not intended for clinical use.